Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-12-21

Clinical Trial Update: The Effect Of Oral Ibandronate In Male Osteoporosis [Phase 3]

View source ↗

Summary

This clinical trial update reports Phase 3 results for oral ibandronate in male osteoporosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ibandronate (ibandronate)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Male Osteoporosis | Phase 3 | Status: COMPLETED | Results posted: 2009-12-21